CHL Medical Partners
North America, Connecticut, United States, Stamford
Description
CHL Medical Partners, an American venture capital firm, invests in biotechnology, molecular diagnostic, and medical device companies.
Investor Profile
CHL Medical Partners has backed more than 50 startups, with 0 new investments in the last 12 months alone. The firm has led 12 rounds, about 24% of its total and boasts 16 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series C (22%)
- Series B (20%)
- Series Unknown (18%)
- Series A (16%)
- Series D (14%)
- Private Equity (6%)
- Debt Financing (2%)
- Seed (2%)
Country Focus
- United States (98%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Health Diagnostics
- Manufacturing
- Medical Device
- Genetics
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
